Symmetric Evidence-Based Validation framework in Translational mode (SEBV - Logic)

Description / Abstract: SEBV-Logic (Symmetric Evidence-Based Validation Logic) represents a novel, agnostic, dual-stream validation architecture designed to establish scientific truth statements regarding clinical outcomes in Allopathic-Resistant Chronic Conditions (ARCC). As the tenth and terminal framework of a comprehensive ten-part scientific corpus, this methodology addresses a persistent epistemological asymmetry in translational medicine: the tendency to reduce traditional medical outcomes to mere allopathic proxies. Core Methodology: The Symmetric Evidence Proposition (SEP-Core) The framework operates on the principle that a clinical outcome is only scientifically valid if it is simultaneously mappable and interpretable through two independent "grammars": Layer I: Allopathic Input (AES): Quantitative biomarkers (e.g., CRP, IL-6, HbA1c), validated clinical scales (e.g., PASI, SCORAD), and diagnostic imaging. Layer II: Ayurvedic Input (AyES): Structured assessments of metabolic status (Prakriti-Vikriti), Dosha-Dushya dynamics, and the Agni-Ama balance. When both data streams converge directionally and temporally, the system generates a Bilateral Validation Signal (BVS), confirming a state of "Symmetric Truth." Standardization and Rigor To eliminate interpretive bias and ensure reproducibility, SEBV-Logic™ incorporates: The 90-Day Resolution Window: a temporal convergence point grounded in both Ayurvedic pharmacodynamics (Kaala/Ritu cycles) and allopathic immunomodulatory evaluation standards. Visual Evidence Standardization Protocol (VESP): a rigorous, legally defensible clinical photography protocol requiring fixed focal lengths, medical-grade lighting (CRI >95), and 18% neutral grey calibration to ensure baseline/follow-up comparability. The Scientific Truth Criterion (STC): a stringent validation requirement, including a 180-day follow-up to confirm sustained pathophysiological recalibration. Scope and Application While agnostic to specific pathologies, the framework is optimized for chronic, non-emergency conditions such as autoimmune, dermatological, and systemic inflammatory disorders where conventional management has documented failure. It provides a formal bridge between distinct medical epistemologies without theoretical reductionism. Usage and Intellectual Property Note: This deposit constitutes a public methodological disclosure for the purpose of establishing scientific priority and intellectual sovereignty. Proprietary Exclusion: the Operational Scoring Manual (OSM), specific Symmetric Evidence Score (SES) formulas, and the BVS Scoring Sheet are proprietary and excluded from this public deposit. Access: institutional research access or commercial exploitation requires a formal Research and Collaboration Agreement or a separate Commercial License with the author. Disclaimer: the author (Valentina Luongo) is the conceptual architect of the methodology and provides no medical advice, diagnosis, or treatment. Clinical responsibility remains exclusively with licensed medical professionals/institutes.